BRACCO DIAGNOSTIC IMAGING
Bracco Diagnostics, Inc. develops and markets clinical agents for use in X-ray/computed tomography, nuclear medicine, and magnetic resonance imaging (MRI) in the United States and Canada. Its products for X-ray/computed tomography include Isovue, an iopamidol injection; Gastrografin, an iodinated radiopaque contrast medium for oral or rectal administration; Cholografin Meglumine, an iodipamide meglumine injection for intravenous cholangiography and cholecystography; Sinografin, a diatrizoate meg... lumine and iodipamide meglumine injection for use in hysterosalpingography; and Cystografin, a diatrizoate meglumine injection for retrograde cystourethrography. The companyรขโฌโขs products for MRI consists of ProHance, a gadolinium-based MRI contrast agent; and MultiHance, a MRI contrast agent to demonstrate weak and transient interactions with serum proteins. Its products for nuclear medicine includes CardioGen-82, a generator-based myocardial perfusion agent; Kinevac, a cholecystopancreatic-gastrointestinal peptide hormone for parenteral administration; Choletec for use as a hepatobiliary imaging agent in cholescintigraphy; MDP-Bracco for use as a bone imaging agent; Chromitope sodium for use in determining red blood cell volume or mass, and studying its survival time; and Bracco A-C-D Solution Modified for use with chromitope sodium in the labeling of red blood cells. In addition, the company provides products for gastroenterology, which encompass a mouthpiece for protection during EGD procedures; components for GI endoscopy; mouthpieces to reduce the risk of hypoxia; in-line suction polyp traps; and polyp retrieval products, as well as offers contrast agents for ultrasound procedures. Further, Bracco Diagnostics offers professional services to health care professionals. It offers its products through a network of representatives. The company was founded in 1994 and is based in Princeton, New Jersey. Bracco Diagnostics, Inc. operates as a subsidiary of Bracco S.p.A.
BRACCO DIAGNOSTIC IMAGING
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
1994-01-01
Address:
Milan, Lombardia, Italy
Country:
Italy
Website Url:
http://www.braccoimaging.com
Total Employee:
1+
Status:
Active
Contact:
+60 9-514 2200
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics Content Delivery Network Google Universal Analytics Nginx Amazon AJAX Libraries API
Similar Organizations
Bionanoplus
Bionanoplus focuses on the development of polymeric nanoparticles and microparticles as controlled release drug delivery systems.
Cizzle Biotech Ltd.
Cizzle Biotech Ltd. focuses on the development of CIZ1 gene and its potential as a diagnostic biomarker.
Diagnostic Healthcare
Diagnostic Healthcare provides diagnostic imaging solutions to healthcare facilities in the UK.
Quantason
Quantason develops bi-modal US/IDUSโข platform technology for diagnostic imaging and active screening.
Current Employees Featured
Founder
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2019-06-27 | Blue Earth Diagnostics | Blue Earth Diagnostics acquired by Bracco Diagnostic Imaging | 450 M USD |
2017-10-18 | SurgVision | SurgVision acquired by Bracco Diagnostic Imaging | N/A |
Official Site Inspections
http://www.braccoimaging.com
- Host name: ec2-34-204-18-91.compute-1.amazonaws.com
- IP address: 34.204.18.91
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149